Lv6
2310 积分 2021-05-11 加入
The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy
18天前
已完结
Atopic dermatitis
20天前
已完结
Differential dynamics of TARC during JAK‐inhibitor therapy compared to biological therapies targeting type 2 inflammation
20天前
已完结
IgA vasculitis (Henoch–Shönlein purpura) in adults: Diagnostic and therapeutic aspects
4个月前
已完结
Cost-effectiveness analysis of first-line pembrolizumab treatment for PD-L1 positive, non-small cell lung cancer in China
4个月前
已完结
Cost-effectiveness of Atezolizumab Plus Bevacizumab vs Sorafenib as First-Line Treatment of Unresectable Hepatocellular Carcinoma
4个月前
已完结
Global epidemiology of dyslipidaemias
4个月前
已完结
Purpura simplex (inflammatory purpura without vasculitis): A clinicopathologic study of 174 cases
5个月前
已完结
Cancer therapy with antibodies
6个月前
已完结
Comprehensive measurement of biopharmaceutical R&D investment
7个月前
已完结
皖公网安备34019202002308
